Medican Enterprises Inc. (MDCND) 0.0068 $MDCND
Medican Enterprises close USD1.0m stock acquisition of TWYNS
M2 - Tue May 12, 6:10AM CDT
Medican Enterprises Inc (OTCBB:MDCN) announced on Tuesday that it has closed its acquisition of TWYNS, a company providing branding services for enterprises in the Cannabidiol (CBD) business.
Medican Enterprises Files 8K Announcing Closing of Acquisition of CBD Branding Company TWYNS
Business Wire - Mon May 11, 7:00AM CDT
Medican Enterprises Inc. (OTCBB:MDCN) ("Medican" or "the Company"

, a merchant bank and bio-pharmaceutical company in the emerging global marijuana industry, announces that further to its press release of April 28, 2014 the Company has closed on its acquisition of TWYNS, a company that provides branding services for enterprises in the Cannabidiol (CBD) business. The transaction is valued at approximately $1,000,000, all in stock and is expected to add approximately $400,000 to Medican's annual revenues.
Medican Enterprises Closes Acquisition of CBD Branding Company TWYNS in All Stock Deal
Business Wire - Wed May 06, 7:00AM CDT
Medican Enterprises Inc. (OTCBB:MDCN) ("Medican" or "the Company"

, a merchant bank and bio-pharmaceutical company in the emerging global marijuana industry, announces that further to its press release of April 28, 2014 the Company has closed on its acquisition of TWYNS, a company that provides branding services for enterprises in the Cannabidiol (CBD) business. The transaction is valued at approximately $1,000,000, all in stock and is expected to add approximately $400,000 to Medican's annual revenues.
Medican Enterprises Signs Definitive Purchase Agreement to Acquire CBD Branding Company TWYNS for All Stock Transaction
Business Wire - Tue Apr 28, 7:00AM CDT
Medican Enterprises Inc. (OTCBB:MDCN) ("Medican" or "the Company"

, a merchant bank and bio-pharmaceutical company in the emerging global marijuana industry, has signed a letter of intent to acquire TWYNS, a company that provides branding services for enterprises in the Cannabidiol (CBD) business. The transaction is valued at approximately $1,000,000, all in stock. TWYNS should add approximately $400,000 to Medican's revenue annually, and Medican is obligated to fund the operations of TWYNS at $12,000 per month.